SeaCrest Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$213K Buy
+1,357
New +$203K 0.02% 511
2025
Q3
Sell
-2,027
Closed -$245K 662
2025
Q2
$245K Sell
2,027
-206
-9% -$23.2K 0.03% 509
2025
Q1
$249K Sell
2,233
-38
-2% -$4.04K 0.03% 551
2024
Q4
$221K Buy
+2,271
New +$242K 0.02% 594
2024
Q1
Sell
-2,139
Closed -$227K 645
2023
Q4
$227K Sell
2,139
-653
-23% -$63K 0.03% 541
2023
Q3
$284K Buy
2,792
+314
+13% +$31.9K 0.04% 475
2023
Q2
$250K Sell
2,478
-235
-9% -$23.5K 0.03% 516
2023
Q1
$250K Buy
2,713
+334
+14% +$29.2K 0.03% 519
2022
Q4
$216K Buy
+2,379
New +$200K 0.03% 538
2022
Q3
Sell
-2,212
Closed -$187K 1197
2022
Q2
$187K Buy
+2,212
New +$194K 0.02% 630
2021
Q1
Sell
-2,174
Closed -$205K 674
2020
Q4
$205K Buy
+2,174
New +$190K 0.03% 561
2019
Q2
Sell
-1,834
Closed -$158K 1402
2019
Q1
$158K Sell
1,834
-174
-9% -$14K 0.03% 541
2018
Q4
$154K Buy
2,008
+76
+4% +$5.92K 0.03% 505
2018
Q3
$149K Hold
1,932
0.03% 612
2018
Q2
$131K Buy
1,932
+287
+17% +$19.8K 0.02% 637
2018
Q1
$119K Hold
1,645
0.02% 647
2017
Q4
$124K Buy
+1,645
New +$124K 0.02% 632

Other funds holding NVS

SeaCrest Wealth Management's NVS Position: Q2 2026 in Review

SeaCrest Wealth Management opened a new position in Novartis (NVS) in Q2 2026: 1,357 shares worth $213K. The stake represents 0.02% of the portfolio and ranks #511 among its holdings. This is a return to the name: SeaCrest Wealth Management previously reported a position in NVS as recently as Q2 2025.

SeaCrest Wealth Management first reported a position in NVS in Q4 2017 and has held it in 17 quarters since. The position peaked at $284K in Q3 2023. 366 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • SeaCrest Wealth Management held 1,357 shares of Novartis worth $213K as of Q2 2026.
  • Novartis was a new SeaCrest Wealth Management position in Q2 2026.
  • Novartis made up 0.02% of SeaCrest Wealth Management's portfolio in Q2 2026, its #511 holding.
  • SeaCrest Wealth Management first reported a position in Novartis in Q4 2017 and has held it in 17 quarters since.
  • SeaCrest Wealth Management's Novartis position peaked at $284K in Q3 2023.
  • 366 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on SeaCrest Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.